Omega-3 fatty acids have an anti-inflammatory and adipogenic effect in adipose tissue. They offer systemic benefits in metabolic and chronic inflammatory diseases. By modulating inflammation and improving insulin sensitivity, they can help reduce obesity and associated diseases such as MASLD, cardiovascular disease, gut dysbiosis and immune-mediated disorders.
Autoren
- Jens Dehn
Publikation
- InFo DIABETOLOGIE & ENDOKRINOLOGIE
Related Topics
You May Also Like
- Myelofibrosis
Mutations and Molecular Diagnostics in Treatment Decisions
- Psoriasis in the Age of Precision Medicine
Systemic Therapy for Patients with Comorbidities: What Is the Best Choice?
- The AMALFI study and the limits of digital screening for atrial fibrillation
Remote monitoring for atrial fibrillation: lots of detection, little stroke prevention?
- MASH
Pharmacotherapies as “Game Changers”—What Are the Upcoming Challenges?
- Obesity Treatment
Oral GLP-1 Therapies: ATTAIN-1 and OASIS-4—The Next Leap Forward
- Older patients with atopic dermatitis
Why the Use of Biologics Is Recommended
- Disorders of the Gut-Brain Interaction
Peppermint-Caraway Oil Supplement Proves Effective in Phase IV Trial
- Gepante for Migraines